)
KALA BIO (KALA) investor relations material
KALA BIO Registration Filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Company overview and business model
Focuses on developing and commercializing therapies for rare and severe eye diseases, with lead candidate KPI-012, a mesenchymal stem cell secretome acquired in 2021.
Incorporated in Delaware in 2009, with principal offices in Arlington, MA.
Financial performance and metrics
Raised $6.0 million in gross proceeds through private placements of Series AA and Series AAA Preferred Stock between November 2025 and January 2026.
As of February 4, 2026, there were 911,330,225 shares of common stock outstanding.
Use of proceeds and capital allocation
Will not receive any proceeds from the resale of shares by selling stockholders; all proceeds go to selling stockholders.
Company bears registration and listing costs, while selling stockholders pay commissions and discounts.
- KPI-012's phase II-B trial for PCED targets a major unmet need, with data expected Q1 2025.KALA
H.C. Wainwright 4th Annual Ophthalmology Virtual Conference2 Feb 2026 - All proposals, including director elections and share increase, passed unanimously.KALA
AGM 20262 Feb 2026 - KPI-012 nears phase IIb readout for PCED, targeting broad unmet needs in rare eye diseases.KALA
Jefferies 2024 Global Healthcare Conference1 Feb 2026 - David Lazar's executive experience highlighted as board nomination is updated for the 2025 meeting.KALA
Proxy Filing26 Jan 2026 - Phase IIb trial for a novel secretome therapy in PCED targets broad approval and billion-dollar market.KALA
Piper Sandler 36th Annual Healthcare Conference11 Jan 2026 - Settlements with Baker Bros. and LifeSci increased outstanding shares to 27.8 million.KALA
Proxy Filing6 Jan 2026 - Proxy seeks approval for director elections, share issuance, capital changes, and auditor ratification.KALA
Proxy Filing30 Dec 2025 - Late-stage trial for a stem cell-based eye drop targets broad PCED market with imminent data.KALA
H.C. Wainwright 27th Annual Global Investment Conference27 Dec 2025 - Virtual meeting to vote on directors, compensation, auditor, share issuances, and capital changes.KALA
Proxy Filing19 Dec 2025
Next KALA BIO earnings date
Next KALA BIO earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)